88 related articles for article (PubMed ID: 15294979)
1. Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations.
Yang R; Murillo FM; Lin KY; Yutzy WH; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Immunol; 2004 Aug; 173(4):2624-31. PubMed ID: 15294979
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Yang R; Murillo FM; Cui H; Blosser R; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Virol; 2004 Oct; 78(20):11152-60. PubMed ID: 15452235
[TBL] [Abstract][Full Text] [Related]
3. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
4. Papillomavirus-like particles induce acute activation of dendritic cells.
Lenz P; Day PM; Pang YY; Frye SA; Jensen PN; Lowy DR; Schiller JT
J Immunol; 2001 May; 166(9):5346-55. PubMed ID: 11313370
[TBL] [Abstract][Full Text] [Related]
5. B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88.
Yang R; Murillo FM; Delannoy MJ; Blosser RL; Yutzy WH; Uematsu S; Takeda K; Akira S; Viscidi RP; Roden RB
J Immunol; 2005 Jun; 174(12):7912-9. PubMed ID: 15944297
[TBL] [Abstract][Full Text] [Related]
6. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
7. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
8. Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity.
Da Silva DM; Fausch SC; Verbeek JS; Kast WM
J Immunol; 2007 Jun; 178(12):7587-97. PubMed ID: 17548594
[TBL] [Abstract][Full Text] [Related]
9. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent Manner.
Pfaender S; Grabski E; Detje CN; Riebesehl N; Lienenklaus S; Steinmann E; Kalinke U; Pietschmann T
PLoS Pathog; 2016 Jul; 12(7):e1005736. PubMed ID: 27385030
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
12. Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.
Balmelli C; Demotz S; Acha-Orbea H; De Grandi P; Nardelli-Haefliger D
J Virol; 2002 Dec; 76(24):12596-602. PubMed ID: 12438585
[TBL] [Abstract][Full Text] [Related]
13. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.
Rudolf MP; Fausch SC; Da Silva DM; Kast WM
J Immunol; 2001 May; 166(10):5917-24. PubMed ID: 11342606
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
Ohlschläger P; Osen W; Dell K; Faath S; Garcea RL; Jochmus I; Müller M; Pawlita M; Schäfer K; Sehr P; Staib C; Sutter G; Gissmann L
J Virol; 2003 Apr; 77(8):4635-45. PubMed ID: 12663770
[TBL] [Abstract][Full Text] [Related]
16. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.
Morón G; Rueda P; Casal I; Leclerc C
J Exp Med; 2002 May; 195(10):1233-45. PubMed ID: 12021304
[TBL] [Abstract][Full Text] [Related]
17. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
18. SHIV virus-like particles bind and activate human dendritic cells.
Zhang R; Li M; Chen C; Yao Q
Vaccine; 2004 Nov; 23(2):139-47. PubMed ID: 15531030
[TBL] [Abstract][Full Text] [Related]
19. Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.
Giannini SL; Hanon E; Moris P; Van Mechelen M; Morel S; Dessy F; Fourneau MA; Colau B; Suzich J; Losonksy G; Martin MT; Dubin G; Wettendorff MA
Vaccine; 2006 Aug; 24(33-34):5937-49. PubMed ID: 16828940
[TBL] [Abstract][Full Text] [Related]
20. [Effect of neonatal BCG vaccination on phenotype and function of splenic dendritic cells of BALB/c mice].
Liu CH; Liu EM; Liu CH; Liu W; Yang XQ; Li X
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):784-8. PubMed ID: 19099886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
